Abhijit Naravane, a partner at PA Consulting, outlines strategies to help biopharma operations leaders successfully navigate ...

The Company expects to receive aggregate gross proceeds of US$8 million from the Offering, before deducting underwriting discounts and other related expenses. The Offering is expected to close on or ...

Though most biopharma investment is in two states, follow this model to bring the research—and investments—elsewhere.

This isn't the first round of tit-for-tat actions between China and the U.S. This time, around, analysts said, China is much better prepared to counter.

AbbVie (ABBV) stock was one of the top gainers in the S&P 500 Friday morning as the biotech firm posted better-than-expected sales and gave strong guidance on higher demand for two of its drugs to ...

Stock futures edged down on Monday as markets assessed China's ChatGPT moment and geared up for a busy week packed with earnings reports from mega-cap tech giants, including Microsoft (MSFT), Meta ...

Analyst Justin Zelin of BTIG maintained a Buy rating on Legend Biotech (LEGN – Research Report), retaining the price target of $91.00. Justin Zelin has given his Buy rating due to a combination ...

For the full calendar of 2024, Abbott recorded sales of $41.95 billion, following the launches last year of a new heart valve repair implant and FDA clearances for two over-the-counter blood sugar ...